VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1551873
Sex: U
Age: 44
State:

Vax Date: 01/02/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Facial swelling; Headache; This spontaneous case was reported by a dentist and describes the occurrence of SWELLING FACE (Facial swelling) and HEADACHE (Headache) in a 44-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037k20A) for COVID-19 vaccination. No Medical History information was reported. On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING FACE (Facial swelling) and HEADACHE (Headache). At the time of the report, SWELLING FACE (Facial swelling) and HEADACHE (Headache) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Additional information added on 18JUN2021 contains no significant information

Other Meds:

Current Illness:

ID: 1551874
Sex: F
Age: 74
State: GA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash size of an orange; blotchy place size of an orange; injection site redness; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (sore arm), RASH MACULAR (blotchy place size of an orange), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE RASH (rash size of an orange) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. No Medical History was provided by the reporter. Concomitant products included ASCORBIC ACID, BETACAROTENE, COPPER, NICOTINAMIDE, SELENIUM, TOCOPHEROL, XANTOFYL, ZINC (LUTEIN +) for Eye discomfort, MULTIVITAMINS [VITAMINS NOS] and ASCORBIC ACID, BIOFLAVONOIDS NOS, HESPERIDIN, MALPIGHIA GLABRA, ROSA CANINA, RUTOSIDE (VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS;HESPERIDIN;MALPIGHIA GLABRA;ROSA CANINA;RUTOSIDE]) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced AXILLARY PAIN (sore arm). On 25-Jan-2021, the patient experienced RASH MACULAR (blotchy place size of an orange) and VACCINATION SITE ERYTHEMA (injection site redness). On an unknown date, the patient experienced VACCINATION SITE RASH (rash size of an orange). The patient was treated with CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]) for Rash, at an unspecified dose and frequency. On 15-Jan-2021, AXILLARY PAIN (sore arm) outcome was unknown. At the time of the report, RASH MACULAR (blotchy place size of an orange), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE RASH (rash size of an orange) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient's concomitant medication included Heart med and Betablockers.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: LUTEIN +; MULTIVITAMINS [VITAMINS NOS]; VITAMIN C [ASCORBIC ACID;BIOFLAVONOIDS NOS;HESPERIDIN;MALPIGHIA GLABRA;ROSA CANINA;RUTOSIDE]

Current Illness:

ID: 1551875
Sex: F
Age: 70
State: AL

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dry mouth; Metallic taste in my mouth; Blistery on her lips; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), DYSGEUSIA (Metallic taste in my mouth) and LIP BLISTER (Blistery on her lips) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History was provided by the reporter. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced DRY MOUTH (Dry mouth), DYSGEUSIA (Metallic taste in my mouth) and LIP BLISTER (Blistery on her lips). At the time of the report, DRY MOUTH (Dry mouth), DYSGEUSIA (Metallic taste in my mouth) and LIP BLISTER (Blistery on her lips) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1551876
Sex: F
Age:
State: KS

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: SARS-CoV-2 test positive; COVID-19; Sore right arm; sinus problems; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SINUS DISORDER (sinus problems), COVID-19 (COVID-19), VACCINATION SITE PAIN (Sore right arm) and SARS-COV-2 TEST POSITIVE (SARS-CoV-2 test positive) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced SINUS DISORDER (sinus problems) and VACCINATION SITE PAIN (Sore right arm). On 11-Jan-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (SARS-CoV-2 test positive). At the time of the report, SINUS DISORDER (sinus problems) and SARS-COV-2 TEST POSITIVE (SARS-CoV-2 test positive) outcome was unknown and COVID-19 (COVID-19) and VACCINATION SITE PAIN (Sore right arm) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, SARS-CoV-2 test positive: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Additional information received: Patient had declined further follow-up.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1551877
Sex: M
Age: 80
State: SC

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced PYREXIA (fever). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant information not provided. Treatment included Aspirin

Other Meds:

Current Illness:

ID: 1551878
Sex: F
Age: 60
State: MN

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen lymph node; Swelling; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling), HEADACHE (Headache) and LYMPHADENOPATHY (swollen lymph node) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling) and HEADACHE (Headache). On 28-Jan-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node). At the time of the report, VACCINATION SITE SWELLING (Swelling), HEADACHE (Headache) and LYMPHADENOPATHY (swollen lymph node) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 25-Apr-2021: NNI

Other Meds:

Current Illness:

ID: 1551879
Sex: M
Age: 61
State: CA

Vax Date: 01/12/2021
Onset Date: 01/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: bedridden; Did not have good balance; Diarrhea; Loss of appetite; Nausea; headache migraine; Dizziness; Head heaviness; Feeling Uncomfortable; Uneasy feeling, Felt foggy; Heart Palpitations; can't even move; can't walk; Feeling stomach upset; Sore Arm; This spontaneous case was reported by a dentist and describes the occurrence of HYPOKINESIA (can't even move), GAIT INABILITY (can't walk), BALANCE DISORDER (Did not have good balance), PALPITATIONS (Heart Palpitations) and DIZZINESS (Dizziness) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Enlarged prostate and GERD. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for Enlarged prostate, OMEPRAZOLE for GERD. On 12-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jan-2021, the patient experienced PALPITATIONS (Heart Palpitations) and FEELING ABNORMAL (Uneasy feeling, Felt foggy). In January 2021, the patient experienced HYPOKINESIA (can't even move), GAIT INABILITY (can't walk), ABDOMINAL DISCOMFORT (Feeling stomach upset) and VACCINATION SITE PAIN (Sore Arm). On 20-Jan-2021, the patient experienced DIZZINESS (Dizziness), HEAD DISCOMFORT (Head heaviness), DISCOMFORT (Feeling Uncomfortable) and NAUSEA (Nausea). 20-Jan-2021, the patient experienced MIGRAINE (headache migraine). On 23-Jan-2021, the patient experienced DECREASED APPETITE (Loss of appetite) and DIARRHOEA (Diarrhea). On 27-Jan-2021, the patient experienced BALANCE DISORDER (Did not have good balance). On an unknown date, the patient experienced BEDRIDDEN (bedridden). At the time of the report, HYPOKINESIA (can't even move), GAIT INABILITY (can't walk), BALANCE DISORDER (Did not have good balance), PALPITATIONS (Heart Palpitations), DIZZINESS (Dizziness), FEELING ABNORMAL (Uneasy feeling, Felt foggy), ABDOMINAL DISCOMFORT (Feeling stomach upset), DISCOMFORT (Feeling Uncomfortable), DECREASED APPETITE (Loss of appetite), BEDRIDDEN (bedridden), DIARRHOEA (Diarrhea) and VACCINATION SITE PAIN (Sore Arm) outcome was unknown and HEAD DISCOMFORT (Head heaviness), MIGRAINE (headache migraine) and NAUSEA (Nausea) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Vital signs measurement: normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered HEAD DISCOMFORT (Head heaviness), MIGRAINE (headache migraine) and NAUSEA (Nausea) to have an unknown relationship. No further causality assessments were provided for HYPOKINESIA (can't even move), GAIT INABILITY (can't walk), BALANCE DISORDER (Did not have good balance), PALPITATIONS (Heart Palpitations), DIZZINESS (Dizziness), FEELING ABNORMAL (Uneasy feeling, Felt foggy), ABDOMINAL DISCOMFORT (Feeling stomach upset), DISCOMFORT (Feeling Uncomfortable), DECREASED APPETITE (Loss of appetite), BEDRIDDEN (bedridden), DIARRHOEA (Diarrhea) and VACCINATION SITE PAIN (Sore Arm). Patient received treatment of Tylenol, Advil for heavy head, Motrin/APAP, Meclizine for head problem and fogginess, unspecified medication for migraine. Patient was also prescribed Zoloft for unspecified condition. Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Patient information, suspect product details,concomitant medications, outcome of the events, linking term for headache migraine updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.

Other Meds: FLOMAX [TAMSULOSIN HYDROCHLORIDE]; OMEPRAZOLE

Current Illness: Enlarged prostate; GERD

ID: 1551880
Sex: F
Age: 74
State: FL

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body really ached; arm was sore; Migraine Headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine Headache), PAIN (Body really ached) and VACCINATION SITE PAIN (arm was sore) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No medical history information was reported. Concomitant products included ZOLMITRIPTAN for Migraine. On 21-Jan-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced MIGRAINE (Migraine Headache) and VACCINATION SITE PAIN (arm was sore). On an unknown date, the patient experienced PAIN (Body really ached). On 24-Feb-2021, MIGRAINE (Migraine Headache) had resolved. At the time of the report, PAIN (Body really ached) and VACCINATION SITE PAIN (arm was sore) had resolved. Not Provided mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: updated event outcome , reporter address, patient demographics.

Other Meds: ZOLMITRIPTAN

Current Illness:

ID: 1551881
Sex: F
Age:
State: FL

Vax Date: 02/04/2021
Onset Date: 02/05/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; fatigue; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), FATIGUE (fatigue) and MYALGIA (muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced CHILLS (chills), FATIGUE (fatigue) and MYALGIA (muscle aches). At the time of the report, CHILLS (chills), FATIGUE (fatigue) and MYALGIA (muscle aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Upon in internal review on 21 May 2021, the age was corrected to unknown age. Concomitant medications were not provided. No treatment information was reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1551882
Sex: F
Age:
State: MD

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; extreme nausea; fatigue; joint pain; sick; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), NAUSEA (extreme nausea), FATIGUE (fatigue), ARTHRALGIA (joint pain) and ILLNESS (sick) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), NAUSEA (extreme nausea), FATIGUE (fatigue), ARTHRALGIA (joint pain) and ILLNESS (sick). At the time of the report, PYREXIA (fever), NAUSEA (extreme nausea), FATIGUE (fatigue), ARTHRALGIA (joint pain) and ILLNESS (sick) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1551883
Sex: M
Age: 71
State: OK

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extremely dizzy; Can't walk without falling - he is on a wheelchair; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (Extremely dizzy) and GAIT DISTURBANCE (Can't walk without falling - he is on a wheelchair) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included METFORMIN for an unknown indication. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced DIZZINESS (Extremely dizzy) and GAIT DISTURBANCE (Can't walk without falling - he is on a wheelchair). At the time of the report, DIZZINESS (Extremely dizzy) and GAIT DISTURBANCE (Can't walk without falling - he is on a wheelchair) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Computerised tomogram: clear (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient was prescribed steroids (unspecified) after 5 days of dizziness and walking difficulty. The reporter states that the steroids helped a little, but the patient never recovered. The patient's HCP recommended the patient receive the second dose. Unknown if the patient received.

Other Meds: METFORMIN

Current Illness:

ID: 1551884
Sex: F
Age:
State:

Vax Date: 01/27/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Reaction; Bright red; Lot of heat; Very itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reaction), ERYTHEMA (Bright red), FEELING HOT (Lot of heat) and PRURITUS (Very itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION COMPLICATION (Reaction), ERYTHEMA (Bright red), FEELING HOT (Lot of heat) and PRURITUS (Very itchy). At the time of the report, VACCINATION COMPLICATION (Reaction), ERYTHEMA (Bright red), FEELING HOT (Lot of heat) and PRURITUS (Very itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1551885
Sex: F
Age: 45
State: KS

Vax Date: 12/28/2020
Onset Date: 01/06/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild illness; Tested positive for COVID; This spontaneous case was reported by a nurse and describes the occurrence of ILLNESS (Mild illness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A-2A) for COVID-19 vaccination. No Medical History information was reported. On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced ILLNESS (Mild illness). At the time of the report, ILLNESS (Mild illness) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. She tested positive for COVID on 1/6/2021 via nasal swab PCR. Concomitant medications were not reported. Treatment information were not provided.

Other Meds:

Current Illness:

ID: 1551886
Sex: F
Age: 52
State: CA

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: little burning on arm; little soreness on arm; Very red hot square at the injection site; very red hot square at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of BURNING SENSATION (little burning on arm), PAIN IN EXTREMITY (little soreness on arm), VACCINATION SITE WARMTH (Very red hot square at the injection site) and VACCINATION SITE ERYTHEMA (very red hot square at the injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. Concurrent medical conditions included Complex regional pain syndrome. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced BURNING SENSATION (little burning on arm), PAIN IN EXTREMITY (little soreness on arm), VACCINATION SITE WARMTH (Very red hot square at the injection site) and VACCINATION SITE ERYTHEMA (very red hot square at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (little burning on arm) and PAIN IN EXTREMITY (little soreness on arm) outcome was unknown and VACCINATION SITE WARMTH (Very red hot square at the injection site) and VACCINATION SITE ERYTHEMA (very red hot square at the injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant product was reported. Treatment drug include Tylenol before bed the same day of the injection for the symptoms and took compounded cream with Ketamine for her knee.

Other Meds:

Current Illness: Complex regional pain syndrome

ID: 1551887
Sex: F
Age: 51
State: OR

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had systemic flu-like symptoms with no fever; arm began to swell 10 days after the vaccine; swelling covered my arm and was one inch from elbow; she noticed a ?red circle that grew bigger during the night; felt crappy for a day; arm hurt for "like a week after the injection"; arm was very painful; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (arm began to swell 10 days after the vaccine; swelling covered my arm and was one inch from elbow), MALAISE (felt crappy for a day), INFLUENZA LIKE ILLNESS (had systemic flu-like symptoms with no fever), PAIN IN EXTREMITY (arm hurt for "like a week after the injection"; arm was very painful) and RASH ERYTHEMATOUS (she noticed a ?red circle that grew bigger during the night) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm hurt for "like a week after the injection"; arm was very painful). On 15-Jan-2021, the patient experienced MALAISE (felt crappy for a day). On 24-Jan-2021, the patient experienced PERIPHERAL SWELLING (arm began to swell 10 days after the vaccine; swelling covered my arm and was one inch from elbow) and RASH ERYTHEMATOUS (she noticed a ?red circle that grew bigger during the night). On 27-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (had systemic flu-like symptoms with no fever). On 15-Jan-2021, MALAISE (felt crappy for a day) had resolved. On 28-Jan-2021, INFLUENZA LIKE ILLNESS (had systemic flu-like symptoms with no fever) had resolved. At the time of the report, PERIPHERAL SWELLING (arm began to swell 10 days after the vaccine; swelling covered my arm and was one inch from elbow) and RASH ERYTHEMATOUS (she noticed a ?red circle that grew bigger during the night) was resolving and PAIN IN EXTREMITY (arm hurt for "like a week after the injection"; arm was very painful) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. On 25JAN2021, the patient sought medical advise from her HCP about the a ?red circle that grew bigger during the night." She reported that her doctor instructed her to elevate her arm with ice and take ibuprofen. The caller stated that the 27JAN2021 and 28JAN2021 were the worst days. On 28JAN2021, the patient emailed her doctor and was prescribed antibiotics. The patient reported that she did not take them; she used a steroid cream instead and the next day her arm started to feel better. The patient also reports taking diphenhydramine.

Other Meds:

Current Illness:

ID: 1551888
Sex: F
Age: 20
State: NY

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: developed hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (developed hives) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced URTICARIA (developed hives). At the time of the report, URTICARIA (developed hives) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1551889
Sex: F
Age: 73
State:

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: it was hot; it was very itchy; rash at the injection site that was quite large about 3 to 5 inches; it was red; it was swollen; typical soreness; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE WARMTH (it was hot), VACCINATION SITE PRURITUS (it was very itchy), MYALGIA (typical soreness), VACCINATION SITE RASH (rash at the injection site that was quite large about 3 to 5 inches) and VACCINATION SITE ERYTHEMA (it was red) in a 73-year-old female patient who received COVID-19 VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Food allergy. Concomitant products included ESTRADIOL for HRT. On 08-Jan-2021, the patient received first dose of COVID-19 VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE) (Intramuscular) dosage was changed to 1 dosage form at an unspecified frequency. On an unknown date, the patient received first dose of COVID-19 VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE) (Intramuscular) 1 dosage form at an unspecified frequency. On 08-Jan-2021, after starting COVID-19 VACCINE MRNA (MRNA 1273) (MODERNA COVID-19 VACCINE), the patient experienced MYALGIA (typical soreness). On 15-Jan-2021, the patient experienced VACCINATION SITE WARMTH (it was hot), VACCINATION SITE PRURITUS (it was very itchy), VACCINATION SITE RASH (rash at the injection site that was quite large about 3 to 5 inches), VACCINATION SITE ERYTHEMA (it was red) and VACCINATION SITE SWELLING (it was swollen). On 31-Jan-2021, VACCINATION SITE WARMTH (it was hot) had resolved. At the time of the report, VACCINATION SITE PRURITUS (it was very itchy), MYALGIA (typical soreness), VACCINATION SITE RASH (rash at the injection site that was quite large about 3 to 5 inches), VACCINATION SITE ERYTHEMA (it was red) and VACCINATION SITE SWELLING (it was swollen) outcome was unknown. con meds: Progesterone, 1mg, oral route, HRT-indication Patient have medication allergy, Ibuprofen allergy, Augmentin allergy, but not allergic to other penicillin's. Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up received: Please confirm NNI

Other Meds: ESTRADIOL

Current Illness: Food allergy

ID: 1551890
Sex: F
Age: 22
State: NY

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph node on the left side that the vaccine was administered; Inflamed; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph node on the left side that the vaccine was administered), VACCINATION SITE INFLAMMATION (Inflamed) and VACCINATION SITE SWELLING (swelling at the injection site) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen lymph node on the left side that the vaccine was administered), VACCINATION SITE INFLAMMATION (Inflamed) and VACCINATION SITE SWELLING (swelling at the injection site). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK dosage form and LORATADINE (CLARITIN [LORATADINE]) at a dose of UNK dosage form. At the time of the report, LYMPHADENOPATHY (Swollen lymph node on the left side that the vaccine was administered) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown and VACCINATION SITE INFLAMMATION (Inflamed) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were provided. According to the patient, the swelling at the injection site was still about the same, but had gone down a bit, at the time of reporting.

Other Meds:

Current Illness:

ID: 1551891
Sex: F
Age:
State: CA

Vax Date: 01/27/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Lightheadedness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and DIZZINESS (Lightheadedness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included CANAGLIFLOZIN (INVOKANA [CANAGLIFLOZIN]), GABAPENTIN, LEVOTHYROXINE SODIUM (LEVOXYL), FOLIC ACID and KCL for an unknown indication. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness) and DIZZINESS (Lightheadedness). At the time of the report, DIZZINESS (Dizziness) and DIZZINESS (Lightheadedness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was reported.

Other Meds: INVOKANA [CANAGLIFLOZIN]; GABAPENTIN; LEVOXYL; FOLIC ACID; KCL

Current Illness:

ID: 1551892
Sex: F
Age: 32
State: PA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: lymph nodes of the side of the injection site swollen; lymph nodes of the side of the injection site swollen painful; headache; chills; soreness of the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness of the arm), HEADACHE (headache), CHILLS (chills), VACCINATION SITE SWELLING (lymph nodes of the side of the injection site swollen) and LYMPH NODE PAIN (lymph nodes of the side of the injection site swollen painful) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (soreness of the arm). On 23-Jan-2021, the patient experienced HEADACHE (headache) and CHILLS (chills). On 25-Jan-2021, the patient experienced VACCINATION SITE SWELLING (lymph nodes of the side of the injection site swollen) and LYMPH NODE PAIN (lymph nodes of the side of the injection site swollen painful). On 22-Jan-2021, VACCINATION SITE PAIN (soreness of the arm) had resolved. On 23-Jan-2021, HEADACHE (headache) and CHILLS (chills) had resolved. On 28-Jan-2021, VACCINATION SITE SWELLING (lymph nodes of the side of the injection site swollen) and LYMPH NODE PAIN (lymph nodes of the side of the injection site swollen painful) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No corrective treatment was provided.

Other Meds:

Current Illness:

ID: 1551893
Sex: F
Age: 38
State: IL

Vax Date: 01/25/2021
Onset Date: 01/27/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: her cheeks swollen; 1 circle on each of her cheeks; tingling sensation; numbness; redness; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (her cheeks swollen), RASH VESICULAR (1 circle on each of her cheeks), PARAESTHESIA (tingling sensation), HYPOAESTHESIA (numbness) and ERYTHEMA (redness) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced SWELLING FACE (her cheeks swollen), RASH VESICULAR (1 circle on each of her cheeks), PARAESTHESIA (tingling sensation), HYPOAESTHESIA (numbness) and ERYTHEMA (redness). At the time of the report, SWELLING FACE (her cheeks swollen), RASH VESICULAR (1 circle on each of her cheeks), PARAESTHESIA (tingling sensation), HYPOAESTHESIA (numbness) and ERYTHEMA (redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were provided as allergy medication No Treatment information provided

Other Meds:

Current Illness:

ID: 1551894
Sex: F
Age: 70
State: TX

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and ABDOMINAL PAIN (Severe colon pain). On 03-Feb-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, ABDOMINAL PAIN (Severe colon pain) outcome was unknown. Not Provided Patient's concomitant drugs included heart medications, thyroid medications and cholesterol medications. No corrective treatment was provided.

Other Meds:

Current Illness: Blood cholesterol abnormal; Heart disorder; Thyroid disorder NOS

ID: 1551895
Sex: F
Age: 62
State: TX

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching at injection site; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No recorded medical history). On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site). On 29-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. On 22-Jan-2021, the patient experienced redness at the injection site that ended on 26-Jan-2021. On 29-Jan-2021, the patient reported that the injection site redness has came back. Concomitant product use was not provided by the reporter. Treatment information was not provided. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1551896
Sex: F
Age: 85
State: WA

Vax Date: 01/17/2021
Onset Date: 01/17/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccination site pain; TIGHT; injection site was red; itchy rash; red spot; shingles; eczema; psoriasis; itching; FEELS LIKE SHE IS LOSING HER MIND; sensitivity in her arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sensitivity in her arm), RASH PRURITIC (itchy rash), RASH MACULAR (red spot), HERPES ZOSTER (shingles) and ECZEMA (eczema) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Previously administered products included for Vaccination: Shingles. On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (sensitivity in her arm), HERPES ZOSTER (shingles), ECZEMA (eczema), PSORIASIS (psoriasis), PRURITUS (itching) and NERVOUS SYSTEM DISORDER (FEELS LIKE SHE IS LOSING HER MIND). On 26-Jan-2021, the patient experienced RASH PRURITIC (itchy rash), RASH MACULAR (red spot), VACCINATION SITE INDURATION (TIGHT) and INJECTION SITE ERYTHEMA (injection site was red). On an unknown date, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, PAIN IN EXTREMITY (sensitivity in her arm), RASH PRURITIC (itchy rash), RASH MACULAR (red spot), VACCINATION SITE INDURATION (TIGHT) and INJECTION SITE ERYTHEMA (injection site was red) was resolving and HERPES ZOSTER (shingles), ECZEMA (eczema), PSORIASIS (psoriasis), PRURITUS (itching), NERVOUS SYSTEM DISORDER (FEELS LIKE SHE IS LOSING HER MIND) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No corrective treatment was provided. Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Added events

Other Meds:

Current Illness:

ID: 1551897
Sex: F
Age:
State: CT

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: got a very strong reaction; had fever of 101?F; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (got a very strong reaction), PYREXIA (had fever of 101?F), CHILLS (chills) and MYALGIA (body aches) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in December 2020. On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (got a very strong reaction), PYREXIA (had fever of 101?F), CHILLS (chills) and MYALGIA (body aches). At the time of the report, VACCINATION COMPLICATION (got a very strong reaction), PYREXIA (had fever of 101?F), CHILLS (chills) and MYALGIA (body aches) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101?F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No corrective treatment was provided. Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Updated events outcome.

Other Meds:

Current Illness:

ID: 1551898
Sex: F
Age: 82
State: TN

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lethargic; Transitory loss of taste; Nausea; Stomach cramping; Fatigue; Didn't feel good; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramping), LETHARGY (Lethargic), AGEUSIA (Transitory loss of taste), FEELING ABNORMAL (Didn't feel good) and NAUSEA (Nausea) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Glaucoma and Allergy (The patient was taking dizol as allergy pill.). Concomitant products included ATENOLOL, AMLODIPINE, LATANOPROST, CALCIUM and COLECALCIFEROL (VIT D [COLECALCIFEROL]) for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FEELING ABNORMAL (Didn't feel good) and FATIGUE (Fatigue). On 27-Jan-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramping). On 28-Jan-2021, the patient experienced LETHARGY (Lethargic), AGEUSIA (Transitory loss of taste) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. On 28-Jan-2021, ABDOMINAL PAIN UPPER (Stomach cramping) and AGEUSIA (Transitory loss of taste) had resolved. At the time of the report, LETHARGY (Lethargic) and NAUSEA (Nausea) had not resolved and FEELING ABNORMAL (Didn't feel good) and FATIGUE (Fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Additional concomitant medications included eye drops for glaucoma (unspecified) and Dizol as allergy pill. Most recent FOLLOW-UP information incorporated above includes: On 17-Apr-2021: Non-significant follow-up information received (consumer denied follow-up as she is doing fine).

Other Meds: ATENOLOL; AMLODIPINE; LATANOPROST; CALCIUM; VIT D [COLECALCIFEROL]

Current Illness: Allergy (The patient was taking dizol as allergy pill.); Glaucoma

ID: 1551899
Sex: F
Age: 76
State: AL

Vax Date: 01/22/2021
Onset Date: 01/23/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Pain in the stomach; Burning head; Weakness; Felt very hot; Discomfort in the stomach; Not feeling hungry; Very weak; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), BURNING SENSATION (Burning head), ASTHENIA (Weakness) and FEELING HOT (Felt very hot) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), BURNING SENSATION (Burning head), ASTHENIA (Weakness), FEELING HOT (Felt very hot), ABDOMINAL DISCOMFORT (Discomfort in the stomach), ABDOMINAL DISTENSION (Not feeling hungry) and ASTHENIA (Very weak). The patient was treated with PARACETAMOL (ADVIL 6 PLUS) at an unspecified dose and frequency. On 25-Jan-2021, PYREXIA (Fever), ABDOMINAL PAIN UPPER (Pain in the stomach), BURNING SENSATION (Burning head), FEELING HOT (Felt very hot), ABDOMINAL DISCOMFORT (Discomfort in the stomach) and ABDOMINAL DISTENSION (Not feeling hungry) had resolved. At the time of the report, ASTHENIA (Weakness) and ASTHENIA (Very weak) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1551900
Sex: F
Age: 53
State: OR

Vax Date: 01/16/2021
Onset Date: 01/25/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Irritation; Itchy; Rash; Red rash on left arm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (Irritation), PRURITUS (Itchy), RASH (Rash) and INJECTION SITE ERYTHEMA (Red rash on left arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 041l20a) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (Many cold medicines---Heart race or pass out. Immediate reaction), Drug allergy (Vicodin ----Nausea and throwing up. Needed to take anti nausea med), Drug allergy (Oxycodone---Nausea and throwing up. Needed to take anti nausea med) and Drug allergy (Anesthesia- Nausea and throwing up. Needed to take anti nausea med). Concomitant products included IBUPROFEN and PARACETAMOL (TYLENOL) for Back pain, MULTIVITAMIN & MINERAL and VIT D [VITAMIN D NOS] for an unknown indication. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 25-Jan-2021, the patient experienced SKIN IRRITATION (Irritation), PRURITUS (Itchy), RASH (Rash) and INJECTION SITE ERYTHEMA (Red rash on left arm). The patient was treated with CORTISONE at an unspecified dose and frequency. On 16-Feb-2021, SKIN IRRITATION (Irritation), PRURITUS (Itchy), RASH (Rash) and INJECTION SITE ERYTHEMA (Red rash on left arm) had resolved. . Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up received on 23 JUNE 2021, vaccine hypersensitivity form was added(date of second dose and outcome of event was added).

Other Meds: MULTIVITAMIN & MINERAL; VIT D [VITAMIN D NOS]; IBUPROFEN; TYLENOL

Current Illness:

ID: 1551901
Sex: M
Age: 51
State: IL

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bad headache; Nausea; Left arm swollen at the injection site; A spontaneous report was received from a consumer concerning a 51-years-old patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events bad headache, nausea, left arm swollen at the injection site, symptoms increased besides the tylenol he took. The patient's medical history was not provided. No relevant concomitant medications were reported. On 27 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: not provided.) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 27 Jan 2021, the patient experienced the event(s) bad headache, nausea, left arm swollen at the injection site. On 28 Jan 2021, the patient experienced the event(s) symptoms increased besides the tylenol he took. Treatment details included Tylenol since 27Jan2021. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), bad headache, nausea, left arm swollen at the injection site, symptoms increased besides the tylenol he took was unknown.

Other Meds:

Current Illness:

ID: 1551902
Sex: M
Age:
State: NC

Vax Date: 01/21/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: phlegm in his throat; This spontaneous case was reported by an other and describes the occurrence of PRODUCTIVE COUGH (phlegm in his throat) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCTIVE COUGH (phlegm in his throat). At the time of the report, PRODUCTIVE COUGH (phlegm in his throat) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Changed the outcome to resolved as patient is fine.

Other Meds:

Current Illness:

ID: 1551903
Sex: F
Age: 78
State: FL

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Entire arm became red; hot to the touch; Low grade fever; Aches; Fever; Chills; Whole arm turned black and blue; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Whole arm turned black and blue), PAIN (Aches), ERYTHEMA (Entire arm became red), FEELING HOT (hot to the touch) and PYREXIA (Fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Blood pressure. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced CONTUSION (Whole arm turned black and blue). On 21-Jan-2021, the patient experienced PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills). On 28-Jan-2021, the patient experienced ERYTHEMA (Entire arm became red), FEELING HOT (hot to the touch) and PYREXIA (Low grade fever). On 21-Jan-2021, CONTUSION (Whole arm turned black and blue) outcome was unknown, PAIN (Aches), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, ERYTHEMA (Entire arm became red) and FEELING HOT (hot to the touch) had not resolved and PYREXIA (Low grade fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided.

Other Meds:

Current Illness: Blood pressure.

ID: 1551904
Sex: F
Age: 39
State: MI

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: had a rash, started down the middle her chest, spread to left side of her stomach, spread a little bit on right arm, spread down all over her legs; diarrhea; felt anxious; chills; sweating; body aches; felt like her body was prickly; A spontaneous report was received from a consumer concerning a 39-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, sweating / hyperhidrosis, body aches /pain, felt like her body was prickly, had a rash, started down the middle her chest, spread to left side of her stomach, spread a little bit on right arm, spread down all over her legs / rash, diarrhea, felt anxious/anxiety. The patient's medical history include allergies, include mold, dust and dogs. Concomitant medications reported were cetirizine hydrochloride, mometasone furoate, vitamins nos, fish oil, for drug use for unknown indication. On 03 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 029L20A) (unknown route) in the left arm for prophylaxis of COVID-19 infection. On 03 Feb 2021, the patient experienced the event(s) chills, sweating, body aches, felt like her body was prickly. On 4 Feb 2021, the patient experienced the event(s) had a rash, started down the middle her chest, spread to left side of her stomach, spread a little bit on right arm, spread down all over her legs, diarrhea, felt anxious. Treatment details included acetaminophen. The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable The outcome of event(s), chills, sweating, body aches, felt like her body was prickly, had a rash, started down the middle her chest, spread to left side of her stomach, spread a little bit on right arm, spread down all over her legs, diarrhea, felt anxious was unknown.

Other Meds: ZYRTEC ALLERGY; FLONASE [MOMETASONE FUROATE]; VITAMINS NOS; FISH OIL

Current Illness: Allergy (Allergies include mold, dust and dogs.)

ID: 1551905
Sex: F
Age: 65
State: CA

Vax Date: 01/25/2021
Onset Date: 01/27/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache.; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache.) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021 at 8:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced HEADACHE (headache.). At the time of the report, HEADACHE (headache.) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The concomitant product is not provided. Treatment is not provided.

Other Meds:

Current Illness:

ID: 1551906
Sex: F
Age: 64
State:

Vax Date: 01/04/2021
Onset Date: 01/05/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness; Small Rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE RASH (Small Rash) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 04-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE RASH (Small Rash). On 09-Jan-2021, VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE RASH (Small Rash) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. ICE used as treatment therapy.

Other Meds:

Current Illness:

ID: 1551907
Sex: M
Age: 75
State: FL

Vax Date: 01/04/2021
Onset Date: 01/29/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness; Chills; Tiredness; Temperature of 98 degress; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), CHILLS (Chills), FATIGUE (Tiredness) and PYREXIA (Temperature of 98 degress) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced PAIN (Soreness), CHILLS (Chills), FATIGUE (Tiredness) and PYREXIA (Temperature of 98 degress). At the time of the report, PAIN (Soreness), CHILLS (Chills) and FATIGUE (Tiredness) outcome was unknown and PYREXIA (Temperature of 98 degress) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Body temperature: 98 (Inconclusive) 98 Degrees. No Concomitant medications were provided No Treatment information provided

Other Meds:

Current Illness:

ID: 1551908
Sex: F
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided No Treatment information provided

Other Meds:

Current Illness:

ID: 1551909
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hypersensitive reaction; Rash in her face and body; This spontaneous case was reported by a physician and describes the occurrence of HYPERSENSITIVITY (Hypersensitive reaction) and RASH (Rash in her face and body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Hypersensitive reaction) and RASH (Rash in her face and body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Hypersensitive reaction) and RASH (Rash in her face and body) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant medications were provided

Other Meds:

Current Illness:

ID: 1551910
Sex: F
Age:
State: WI

Vax Date: 01/29/2021
Onset Date: 01/29/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt warm; Felt like heart was going really fast; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt warm) and PALPITATIONS (Felt like heart was going really fast) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced FEELING HOT (Felt warm) and PALPITATIONS (Felt like heart was going really fast). At the time of the report, FEELING HOT (Felt warm) and PALPITATIONS (Felt like heart was going really fast) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medications were provided No Treatment information provided

Other Meds:

Current Illness:

ID: 1551911
Sex: F
Age:
State:

Vax Date: 02/03/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Did not sleep very well overnight; Achy; Headache; Nausea; Fatigue; Chills; Soreness at injection site; Flu-like symptoms; This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), MIDDLE INSOMNIA (Did not sleep very well overnight), PAIN (Achy), HEADACHE (Headache) and NAUSEA (Nausea) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN (Achy), HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue), CHILLS (Chills) and VACCINATION SITE PAIN (Soreness at injection site). On 05-Feb-2021, the patient experienced MIDDLE INSOMNIA (Did not sleep very well overnight). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), MIDDLE INSOMNIA (Did not sleep very well overnight), PAIN (Achy), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown and HEADACHE (Headache) and VACCINATION SITE PAIN (Soreness at injection site) had not resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant product use was reported. No treatment details were provided.

Other Meds:

Current Illness:

ID: 1551912
Sex: M
Age: 55
State: NJ

Vax Date: 01/19/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Right arm sensitive to the touch; Injection site is hot to the touch; Fever; hard 1.5 inch diameter around the injection site; redness in right arm; Pain in right arm; Right arm swollen; slight pain on the left arm after the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of HYPERAESTHESIA (Right arm sensitive to the touch), VACCINATION SITE WARMTH (Injection site is hot to the touch), PYREXIA (Fever), VACCINATION SITE INDURATION (hard 1.5 inch diameter around the injection site) and VACCINATION SITE ERYTHEMA (redness in right arm) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERAESTHESIA (Right arm sensitive to the touch), VACCINATION SITE WARMTH (Injection site is hot to the touch), PYREXIA (Fever), VACCINATION SITE INDURATION (hard 1.5 inch diameter around the injection site), VACCINATION SITE ERYTHEMA (redness in right arm), VACCINATION SITE PAIN (Pain in right arm), INJECTION SITE SWELLING (Right arm swollen) and INJECTION SITE PAIN (slight pain on the left arm after the vaccination). At the time of the report, HYPERAESTHESIA (Right arm sensitive to the touch), VACCINATION SITE WARMTH (Injection site is hot to the touch), PYREXIA (Fever), VACCINATION SITE INDURATION (hard 1.5 inch diameter around the injection site), VACCINATION SITE ERYTHEMA (redness in right arm), VACCINATION SITE PAIN (Pain in right arm), INJECTION SITE SWELLING (Right arm swollen) and INJECTION SITE PAIN (slight pain on the left arm after the vaccination) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication information was provided. No treatment medication were provided. This case was linked to MOD-2021-079539, MOD-2021-079539. Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Live follow up received on 16-Apr-2021: Event related information added. On 11-Jul-2021: Updated event outcome from unknown to recovered resolved

Other Meds:

Current Illness:

ID: 1551913
Sex: F
Age: 56
State: NC

Vax Date: 01/14/2021
Onset Date: 01/20/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: throat numb; throat tingly; mouth numb; mouth tingly; arm very warm to touch; arm swollen up; arm very red; This spontaneous case was reported by an other health care professional and describes the occurrence of PHARYNGEAL HYPOAESTHESIA (throat numb), OROPHARYNGEAL DISCOMFORT (throat tingly), HYPOAESTHESIA ORAL (mouth numb), STOMATITIS (mouth tingly) and VACCINATION SITE WARMTH (arm very warm to touch) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included HCTZ, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and ESTRADIOL (VIVELLE [ESTRADIOL]) for an unknown indication. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PHARYNGEAL HYPOAESTHESIA (throat numb), OROPHARYNGEAL DISCOMFORT (throat tingly), HYPOAESTHESIA ORAL (mouth numb), STOMATITIS (mouth tingly), VACCINATION SITE WARMTH (arm very warm to touch), VACCINATION SITE SWELLING (arm swollen up) and VACCINATION SITE ERYTHEMA (arm very red). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing from 20-Jan-2021 at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 20-Jan-2021 to 22-Jan-2021 for Numbness, at a dose of 25 mg. On 24-Jan-2021, PHARYNGEAL HYPOAESTHESIA (throat numb), OROPHARYNGEAL DISCOMFORT (throat tingly), HYPOAESTHESIA ORAL (mouth numb), STOMATITIS (mouth tingly), VACCINATION SITE WARMTH (arm very warm to touch), VACCINATION SITE SWELLING (arm swollen up) and VACCINATION SITE ERYTHEMA (arm very red) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 20 Jan 2021, the patient reported her arm started to swell and she has numbness and tingling in her mouth, neck and throat. On 24 Jan 2021 she recovered from the events of swelling, numbness and tingling in her mouth, neck and throat . This case was linked to MOD-2021-237552. Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up information received on 25 JUN 2021, updated patient demography and concomitant medications.

Other Meds: HCTZ; PROTONIX [OMEPRAZOLE]; VIVELLE [ESTRADIOL]

Current Illness:

ID: 1551914
Sex: M
Age: 90
State: TX

Vax Date: 01/22/2021
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: weakness; lightheadness/dizziness; Headache; fatigue; pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), DIZZINESS (lightheadness/dizziness), HEADACHE (Headache), FATIGUE (fatigue) and VACCINATION SITE PAIN (pain in arm) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included TIA (It was a slight blood clot that disappeared after 30 minutes and he was released from the hospital after two days of observation.) on 06-Dec-2020 and Clot blood. Concurrent medical conditions included Migraine headache, Blood pressure and Cholesterol. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol, METOPROLOL for Hypertension, RIVAROXABAN (XARELTO) and CLOPIDOGREL BISULFATE (PLAVIX) for Thrombus. On 22-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), DIZZINESS (lightheadness/dizziness), HEADACHE (Headache), FATIGUE (fatigue) and VACCINATION SITE PAIN (pain in arm). At the time of the report, ASTHENIA (weakness), DIZZINESS (lightheadness/dizziness), HEADACHE (Headache), FATIGUE (fatigue) and VACCINATION SITE PAIN (pain in arm) had resolved. Treatment information were not provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: TCR form includes Outcome of the events as resolved.

Other Meds: METOPROLOL; XARELTO; PLAVIX; LIPITOR

Current Illness: Blood pressure; Cholesterol; Migraine headache

ID: 1551915
Sex: M
Age: 71
State: FL

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Wrist became inflammed and in pain, dr said flare of carpal tunnel now in both wrists, but worse on left arm; Joint pain in arm and shoulder-left side; Injection site soreness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CARPAL TUNNEL SYNDROME (Wrist became inflammed and in pain, dr said flare of carpal tunnel now in both wrists, but worse on left arm), INJECTION SITE PAIN (Injection site soreness) and ARTHRALGIA (joint pain in arm and shoulder-left side) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE PAIN (Injection site soreness). On an unknown date, the patient experienced CARPAL TUNNEL SYNDROME (Wrist became inflammed and in pain, dr said flare of carpal tunnel now in both wrists, but worse on left arm) and ARTHRALGIA (joint pain in arm and shoulder-left side). At the time of the report, CARPAL TUNNEL SYNDROME (Wrist became inflammed and in pain, dr said flare of carpal tunnel now in both wrists, but worse on left arm), INJECTION SITE PAIN (Injection site soreness) and ARTHRALGIA (joint pain in arm and shoulder-left side) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product used included blood thinner. The week following vaccination, the patient wrists became inflamed and in pain. Their doctor said it was flare up of carpal tunnel, which is now in both wrists, but worse in the left arm. Treatment for the events included ice. No prescription medications were provided. The patient has recovered with no problems. Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up information was received and processed the same time as initial report. Follow-up information from the patient indicated they recovered.

Other Meds:

Current Illness:

ID: 1551916
Sex: M
Age: 51
State: TX

Vax Date: 02/04/2021
Onset Date: 02/04/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling in arm; Redness; Fever; Injection site is hurting really bad; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in arm), ERYTHEMA (Redness), PYREXIA (Fever) and VACCINATION SITE PAIN (Injection site is hurting really bad) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012m20a) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included ALPRAZOLAM (XANAX) and ENOXAPARIN SODIUM (CLEXANE) for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Injection site is hurting really bad). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling in arm), ERYTHEMA (Redness) and PYREXIA (Fever). At the time of the report, PERIPHERAL SWELLING (Swelling in arm), ERYTHEMA (Redness), PYREXIA (Fever) and VACCINATION SITE PAIN (Injection site is hurting really bad) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. The patient post receiving their first dose of vaccine stated their left arm at injection site was hurting really bad. On 20-Apr-2021, the patient reported that they experienced swelling in arm, redness and fever post receiving the first dose of vaccine. Reportedly, the patient took the second dose on 04-Mar-2021. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up was received on 20-Apr-2021 and added additional events experienced after first dose. Updated the Action taken. Included second dose date in I-narrative supplement.

Other Meds: XANAX; CLEXANE

Current Illness:

ID: 1551917
Sex: F
Age: 56
State: TX

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feeling chills all day; This spontaneous case was reported by an other and describes the occurrence of CHILLS (Feeling chills all day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 30-Jan-2021, the patient experienced CHILLS (Feeling chills all day). At the time of the report, CHILLS (Feeling chills all day) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1551918
Sex: F
Age: 86
State: MI

Vax Date: 01/11/2021
Onset Date: 01/18/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchy at the point of injection; Slight rash at the point of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy at the point of injection) and VACCINATION SITE RASH (Slight rash at the point of injection) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 206L20A) for COVID-19 vaccination. No medical history was provided by reporter. No concomitant medication reported. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy at the point of injection) and VACCINATION SITE RASH (Slight rash at the point of injection). On 27-Jan-2021, VACCINATION SITE RASH (Slight rash at the point of injection) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itchy at the point of injection) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant product use was reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Additional information added on 24JUN2021 contains non significant information. Patient had concerns about the form and how to provide more information if needed.

Other Meds:

Current Illness:

ID: 1551919
Sex: F
Age:
State:

Vax Date: 01/14/2021
Onset Date: 01/26/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 2 raised bumps on her arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (2 raised bumps on her arm at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE SWELLING (2 raised bumps on her arm at the injection site). At the time of the report, VACCINATION SITE SWELLING (2 raised bumps on her arm at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1551920
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Reaction to the shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Reaction to the shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Reaction to the shot). At the time of the report, VACCINATION SITE REACTION (Reaction to the shot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1551921
Sex: M
Age: 23
State: NJ

Vax Date: 01/27/2021
Onset Date: 01/29/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Low blood pressure; Swelling on lymph nodes; Fever; Sore arm; Chills; Fast heart beating; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTENSION (Low blood pressure), LYMPHADENOPATHY (Swelling on lymph nodes), PYREXIA (Fever), VACCINATION SITE PAIN (Sore arm) and CHILLS (Chills) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced HYPOTENSION (Low blood pressure), LYMPHADENOPATHY (Swelling on lymph nodes), PYREXIA (Fever), VACCINATION SITE PAIN (Sore arm), CHILLS (Chills) and TACHYCARDIA (Fast heart beating). At the time of the report, HYPOTENSION (Low blood pressure), LYMPHADENOPATHY (Swelling on lymph nodes), PYREXIA (Fever), VACCINATION SITE PAIN (Sore arm), CHILLS (Chills) and TACHYCARDIA (Fast heart beating) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2019, COVID-19: Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1551922
Sex: F
Age: 72
State: TX

Vax Date: 01/23/2021
Onset Date: 01/25/2021
Rec V Date: 08/13/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced TENDERNESS (Tenderness), CHILLS (Chills) and LYMPHADENOPATHY (Lymph nodes swelling under the right arm). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] 25-Jan-2021 for Adverse event, at a dose of 500 milligram once a day. At the time of the report, TENDERNESS (Tenderness) and CHILLS (Chills) outcome was unknown and LYMPHADENOPATHY (Lymph nodes swelling under the right arm) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm